Cystatin C and risk of heart failure in the Physicians' Health Study (PHS)
about
Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart AssociationEpidemiology and risk profile of heart failureHeart disease and stroke statistics--2011 update: a report from the American Heart AssociationHeart disease and stroke statistics--2014 update: a report from the American Heart AssociationHeart disease and stroke statistics--2012 update: a report from the American Heart AssociationHeart Disease and Stroke Statistics-2017 Update: A Report From the American Heart AssociationConformational transitions induced by in vitro macromolecular crowding lead to the amyloidogenesis of buffalo heart cystatin.Diminished renal function and the incidence of heart failure.Fasting plasma insulin, C-peptide and cognitive change in older men without diabetes: results from the Physicians' Health Study II.Association of cystatin C with adverse outcomes.Cystatin C increases in cardiac injury: a role in extracellular matrix protein modulationChronic kidney disease and the risk of heart failure in menErythrocyte stearidonic acid and other n-3 fatty acids and CHD in the Physicians' Health Study.Red blood cell MUFAs and risk of coronary artery disease in the Physicians' Health Study.Secreted klotho and chronic kidney diseaseCystatin C, CRP, log TG/HDLc and metabolic syndrome are associated with microalbuminuria in hypertension.Cystatin C: a step forward in assessing kidney function and cardiovascular risk.Risk stratification and short-term prognosis in acute heart failure syndromes: a review of novel biomarkers.Structural and functional studies on a variant of cystatin purified from brain of Capra hircus.Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care.Cystatin C and cardiac hypertrophy in primary hypertension.Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitamins.Effect of olmesartan medoxomil on cystatin C level, left ventricular hypertrophy and diastolic function.Effects of nitroglycerin or pentaerithrityl tetranitrate treatment on the gene expression in rat hearts: evidence for cardiotoxic and cardioprotective effects.Investigating the preventive effects of baicalin and gallocatechin against glyoxal-induced cystatin aggregation.Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis.Kidney markers predict mortality in patients with HIV disease
P2860
Q22306356-59FBFC83-EAF9-42BF-A575-6CAA92CD530EQ24630778-71547FAD-E857-4680-88AB-F2D0E717B1E6Q29547236-F1B692D5-D036-4DE3-903E-133756F5B970Q29547691-8D6BDD3A-E0B5-4EA5-BF7A-9097F71D5DD3Q29547909-EDFA7BEA-015B-4074-8B0D-6FBC413373AEQ30238784-53C96D81-BA94-46B8-AFC5-59F7EE2B8CA2Q30375808-B97FB3E0-805E-43E0-8B37-2DE3F1FDB2C6Q33654021-8552E836-47E3-44A0-B801-0BF7EC26950EQ33906585-623889BE-FD7E-43D6-8336-D1E22C454398Q33932292-622BCDC1-88E3-42E6-82DF-DF6DAA94CE82Q34062726-F3B99B27-9DF3-47F8-BB2A-E3A37EC36083Q34687362-A4476723-7C1B-4975-A1A4-09A56D7C0577Q36853173-5AC51486-826B-497F-90F7-6A8D9001EB62Q37095983-88D96F8B-48DC-424A-88A5-88A4684FAA86Q37190542-337B14A6-CC5E-4B22-B0D2-E5B80F3E5D3FQ37703935-59C648B8-32D7-4772-9F2A-B86E36AA4A66Q37856794-7A584BE4-0FC2-4A1B-B045-F99B2888F06CQ37870921-03377E67-F75D-415D-A185-DE2B4D766171Q39745129-0A93E01F-C507-4926-BA7B-4559A6942577Q39874478-7E418975-2369-4C42-B921-A13926D7643EQ43180532-D28D9AFF-3640-4FD3-87AA-85C79775E4A3Q43291657-8F2210DA-0D02-49FF-ADAA-933BD6D99B93Q45971699-65D5F244-DE75-4961-9191-DD18C9232FE8Q46024791-B5311065-A38D-4CD5-91F6-6091817E0DB6Q47397251-E681E063-F904-4B9C-921E-A48A8AE9D8D3Q51181204-AA47FCB1-92B0-4380-B57B-62030BE960A6Q57690978-4D1DAE59-425B-4E6E-9D94-F80CE40C4C22
P2860
Cystatin C and risk of heart failure in the Physicians' Health Study (PHS)
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Cystatin C and risk of heart failure in the Physicians' Health Study (PHS)
@ast
Cystatin C and risk of heart failure in the Physicians' Health Study (PHS)
@en
Cystatin C and risk of heart failure in the Physicians' Health Study (PHS)
@nl
type
label
Cystatin C and risk of heart failure in the Physicians' Health Study (PHS)
@ast
Cystatin C and risk of heart failure in the Physicians' Health Study (PHS)
@en
Cystatin C and risk of heart failure in the Physicians' Health Study (PHS)
@nl
prefLabel
Cystatin C and risk of heart failure in the Physicians' Health Study (PHS)
@ast
Cystatin C and risk of heart failure in the Physicians' Health Study (PHS)
@en
Cystatin C and risk of heart failure in the Physicians' Health Study (PHS)
@nl
P2860
P1476
Cystatin C and risk of heart failure in the Physicians' Health Study (PHS)
@en
P2093
J Michael Gaziano
Luc Djoussé
P2860
P356
10.1016/J.AHJ.2007.08.023
P407
P50
P577
2008-01-01T00:00:00Z